Similar articles for PMID: 32606050

Year	Number of Results
2020	37
2021	34
2022	26
2023	14
2024	7

1

COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach.

Cheng F, Rao S, Mehra R. Cheng F, et al. Cleve Clin J Med. 2020 Jun 30. doi: 10.3949/ccjm.87a.ccc037. Online ahead of print. Cleve Clin J Med. 2020. PMID: 32606050 Free article.

2

Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations.

Aleem A, Vaqar S. Aleem A, et al. 2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34033365 Free Books & Documents.

3

Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2.

Bess A, Berglind F, Mukhopadhyay S, Brylinski M, Alvin C, Fattah F, Wasan KM. Bess A, et al. Front Pharmacol. 2023 Dec 22;14:1297924. doi: 10.3389/fphar.2023.1297924. eCollection 2023. Front Pharmacol. 2023. PMID: 38186640 Free PMC article.

4

Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus (COVID-19) In The Emergency Department.

Aleem A, Olarewaju O, Pozun A. Aleem A, et al. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34662075 Free Books & Documents.

5

Providing Access To Monoclonal Antibody Treatment Of Coronavirus (COVID-19) Patients In Rural And Underserved Areas.

Wood DA, Aleem A, Davis D. Wood DA, et al. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34662052 Free Books & Documents.

6

Current Strategies of Antiviral Drug Discovery for COVID-19.

Mei M, Tan X. Mei M, et al. Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021. Front Mol Biosci. 2021. PMID: 34055887 Free PMC article. Review.

7

Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.

Martin WR, Cheng F. Martin WR, et al. J Proteome Res. 2020 Nov 6;19(11):4670-4677. doi: 10.1021/acs.jproteome.0c00397. Epub 2020 Sep 27. J Proteome Res. 2020. PMID: 32907334 Free PMC article.

8

[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].

Plaze M, Attali D, Petit AC, Blatzer M, Simon-Loriere E, Vinckier F, Cachia A, Chrétien F, Gaillard R. Plaze M, et al. Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29. Encephale. 2020. PMID: 32387014 Free PMC article. French.

9

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.

Reiter RJ, Sharma R, Simko F, Dominguez-Rodriguez A, Tesarik J, Neel RL, Slominski AT, Kleszczynski K, Martin-Gimenez VM, Manucha W, Cardinali DP. Reiter RJ, et al. Cell Mol Life Sci. 2022 Feb 20;79(3):143. doi: 10.1007/s00018-021-04102-3. Cell Mol Life Sci. 2022. PMID: 35187603 Free PMC article. Review.

10

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.

Wagoner J, Herring S, Hsiang TY, Ianevski A, Biering SB, Xu S, Hoffmann M, Pöhlmann S, Gale M Jr, Aittokallio T, Schiffer JT, White JM, Polyak SJ. Wagoner J, et al. Microbiol Spectr. 2022 Oct 26;10(5):e0333122. doi: 10.1128/spectrum.03331-22. Epub 2022 Oct 3. Microbiol Spectr. 2022. PMID: 36190406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year